We have studied changes in the IGF axis in an ovine model of myocardial inf
arction (MI), in order to determine the relationship between time-based cha
nges in post-infarct myocardium and IGF levels. IGF localization was studie
d by immunocytochemistry, production by in situ hybridization, and specific
binding by radioligand studies.
In surviving tissue, IGF-I peptide localized to cardiomyocytes, with strong
est immunostaining at 1 and 2 days post-infarct in the immediate border are
a adjoining the infarct, where IGF-I mRNA also increased, reaching a maximu
m at 2 days. Binding of radiolabelled IGF-I in surviving tissue was initial
ly lower than that seen in cardiomyocytes in control myocardium, subsequent
ly increasing to become significantly greater by 6 days post-infarct.
In necrotic tissue, IGF-I peptide was still detectable in cardiomyocytes at
0.5 days post-infarct, but had cleared From this area by 1 day, becoming d
etectable again at 6 days post-infarct in macrophages and fibroblasts infil
trating the repair zone. IGF-I mRNA was not detected in necrotic tissue unt
il 6 days, when probe hybridized to macrophages and fibroblasts. Within the
necrotic zone, high levels of radiolabelled IGF-I binding to a combination
of receptors and binding proteins were observed in cardiomyocytes in islan
ds of viable tissue located close to the border.
Weak immunostaining for IGF-II was observed in cardiomyocytes of the surviv
ing tissue. IGF-II mRNA was not detected in either surviving or necrotic ar
eas. Binding of radiolabelled IGF-II was predominantly to macrophages in bo
th surviving and infarct areas, although as with IGF-I, high levels of bind
ing of radiolabelled IGF-II to a combination of receptors and binding prote
ins were observed in islands of viable tissue close to the border within th
e necrotic area.
We conclude that, following MI, surviving cardiomyocytes at the infarct bor
der show marked changes in IGF-I localization, production, and specific bin
ding, indicating that the IGF axis is directly involved in post-infarct eve
nts, possibly in the maintenance of cardiac function by the induction of hy
pertrophy and in cell survival by decreasing apoptotic cell death, which ha
s been demonstrated in other cell types.